The 7 analysts offering 12-month price forecasts for X4 Pharmaceuticals Inc have a median target of 22.00, with a high estimate of 27.00 and a low estimate of 16.00. The median estimate represents a +136.31% increase from the last price of 9.31.
The current consensus among 8 polled investment analysts is to Buy stock in X4 Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.83
Reporting Date Mar 06
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.